News for Biomerica, Inc. (BMRA)

U.S. stock markets experienced a downturn on Thursday, with the Nasdaq Composite shedding over 170 points and ending the day at 19,338.29.

January 16, 2025 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a go-to platform for big investing ideas for stock traders, including b...

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling over 150 points on Thursday. The Dow traded down 0.27% to 43,106.65 while...

U.S. stocks traded mixed midway through trading, with the Dow Jones index gaining around 0.1% on Thursday. The Dow traded up 0.08% to 43,256.69 while the NASDA...

U.S. stocks traded slightly lower this morning, with the Dow Jones index falling around 0.2% on Thursday. Following the market opening Thursday, the Dow traded...

- 10-Minute PSA Test for Early Detection of Prostate Specific Antigen (PSA), an Early Warning Sign of Prostate Cancer - Prostate Cancer: The Second Most Common

- Total Revenue Increases 5% Year-Over-Year - Achieves Sustained Revenue Growth, Improved Gross Margins, and Significant Cost Savings

New patents position Biomerica to address multi-billion-dollar markets in Europe, including GERD ($4 billion+), Crohn's Disease ($2.5 billion+), and Ulcerative

**media[459326]**

Total Revenue Increases 6% Over Same Period Last Year Cost-Saving Measures Now Implemented, Expected to Reduce Annual Expenses by 16% to...

Intense competition among key players drives innovation and product differentiation in the helicobacter pylori non-invasive testing market....

Shares of Motus GI Holdings, Inc. (NASDAQ: MOTS) shares fell sharply in pre-market trading after the company priced its $5 million public offering. Motus GI Holdings shares dipped 46.5% to $1.15 in pre-market trading. Here are some other stocks moving in pre-market trading.

Infobird Co., Ltd (IFBD) is up over 80% in Tuesday's pre-market trading. The following are some of the other stocks making big moves..

Shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) fell sharply during Monday’s session after the company and POINT Biopharma announced topline results from the pivotal phase 3 SPLASH study in metastatic castration-resistant prostate cancer.

NEW YORK, Sept. 22, 2023 (GLOBE NEWSWIRE) -- Maxim Group LLC, a full-service investment banking, securities and wealth management firm, and M-Vest, a...

Kenny has proven track record of driving growth at companies within the healthcare space and holds significant management and public company board...

/PRNewswire/ -- The "At-Home Diagnostic Testing Markets and Trends (COVID-19, FOB, Glucose, HIV and Other Tests) 2023" report has been added to...

/PRNewswire/ -- The

Global blood testing market growth is driven by growing concerns about viruses and chronic diseases. In 2021, North America held the largest share of the...